Ajooni Biotech share price
NSE: AJOONIFMCGPackaged Foods
Ajooni Biotech at a glance
Ajooni Biotech (NSE: AJOONI) closed at ₹2.87 on 22 Oct 2026, down 0.35% on the day. With a market capitalisation of ₹49 Cr, it ranks 3082nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the FMCG sector; its industry is Packaged Foods.
At its last close the stock traded at 14.3× trailing earnings, against a return on equity of 3.8% in FY25. Over the past year the share price has fallen 44.1%. Its 52-week range is ₹2.68 (12 Oct 2026) to ₹5.50 (9 Feb 2026); the last close is 47.8% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹61 Cr (+107.1% year on year) and net profit ₹1 Cr (−38.3%), on a standalone basis. Promoters held 26.89% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹49 CrRank 3082 on NSE
- P/E (trailing)
- 14.3×
- Price to book
- 1.1×FY25
- EPS (TTM)
- ₹0.25to Q4 FY26
- ROE
- 3.8%FY25
- ROCE
- 5.2%FY25
- Debt to equity
- 0.06FY25
- Net profit margin
- 2.9%FY25
- Book value / share
- ₹5.11FY25
- 52-week high
- ₹5.509 Feb 2026
- 52-week low
- ₹2.6812 Oct 2026
- 1-year return
- −44.1%
- RSI (14-day)
- 29.4
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.35% | −8.3% | −10.0% | −28.6% | −44.1% |
Ajooni Biotech quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹26 Cr | ₹26 Cr | ₹34 Cr | ₹29 Cr | ₹31 Cr | ₹32 Cr | ₹59 Cr | ₹61 Cr |
| Revenue YoY | +22.2% | +32.0% | +69.7% | +49.5% | +21.9% | +23.4% | +72.6% | +107.1% |
| Net profit | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
| Net profit YoY | +17.5% | +55.0% | +65.9% | +69.2% | +66.0% | +50.0% | +126.0% | −38.3% |
| Net margin | 1.8% | 2.4% | 2.1% | 5.3% | 2.5% | 2.9% | 2.8% | 1.6% |
| EPS | ₹0.03 | ₹0.04 | ₹0.04 | ₹0.09 | ₹0.02 | ₹0.08 | ₹0.10 | ₹0.05 |
Ajooni Biotech financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹40 Cr | ₹51 Cr | ₹74 Cr | ₹74 Cr | ₹80 Cr | ₹115 Cr |
| Operating profit | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr |
| Net profit | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr |
| EPS (₹) | ₹0.41 | ₹0.37 | ₹1.05 | ₹1.94 | ₹0.25 | ₹0.20 |
| Cash from operations | −₹4 Cr | ₹1 Cr | ₹4 Cr | −₹6 Cr | −₹4 Cr | −₹18 Cr |
| Total debt | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Shareholders' equity | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹42 Cr | ₹43 Cr | ₹88 Cr |
Ajooni Biotech shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 26.89% | 26.89% | 26.89% | 26.89% | 26.89% | 26.89% |
| Non-institutions | 73.11% | 73.11% | 73.11% | 73.11% | 73.11% | 73.11% |
Ajooni Biotech vs peers
The listed FMCG companies nearest to Ajooni Biotech by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| WARRENTEAWarren Tea | — | — | — | ₹54 Cr | — | — |
| AJOONIAjooni Biotech | ₹2.87 | −0.35% | −44.1% | ₹49 Cr | 14.3 | — |
| ANJANIFOODSAnjani Foods | — | — | — | ₹48 Cr | — | — |
| PRUDMOULIPrudential Sugar Corporation | ₹14.30 | −0.56% | −43.3% | ₹46 Cr | 7.7 | — |
| KRETTOSYSKretto Syscon | — | — | — | ₹46 Cr | — | — |
| RONIRoni Households | — | — | — | ₹45 Cr | — | — |
| GROWINGTONGrowington Vent | — | — | — | ₹45 Cr | — | — |
Ask anything about Ajooni Biotech
Pivot answers on the live chart with evidence you can check, and tests strategies against AJOONI's own history. Try: “Why has AJOONI moved over the last three months?” · “Backtest a 50-day moving-average crossover on AJOONI over five years” · “Compare AJOONI with WARRENTEA on margins and valuation”
Frequently asked questions about Ajooni Biotech
What is the share price of Ajooni Biotech today?
Ajooni Biotech (NSE: AJOONI) last closed at ₹2.87 on 22 Oct 2026. Its 52-week high is ₹5.50 and its 52-week low is ₹2.68.
What is the market cap of Ajooni Biotech?
Ajooni Biotech's market capitalisation is ₹49 Cr (₹49 Cr) at the 22 Oct 2026 close, ranking 3082nd among the NSE companies Pivot tracks.
What is the P/E ratio of Ajooni Biotech?
Ajooni Biotech trades at a trailing P/E of 14.3.
What is the ROE and ROCE of Ajooni Biotech?
Return on equity was 3.8% in FY25 and return on capital employed was 5.2% in FY25 (standalone figures).
Is Ajooni Biotech a debt-free company?
No. Ajooni Biotech's debt-to-equity ratio was 0.06 in FY25, with total debt of ₹2 Cr.
What were Ajooni Biotech's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Ajooni Biotech reported revenue of ₹61 Cr, +107.1% year on year, and net profit of ₹1 Cr, −38.3% year on year.
How has Ajooni Biotech stock performed over the last year?
Ajooni Biotech's share price has fallen 44.1% over the past year, −28.6% over three months and −10.0% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Ajooni Biotech?
As of 30 Jun 2026: promoters 26.89%, non-institutions 73.11%.
Who are Ajooni Biotech's competitors?
The listed FMCG companies closest to Ajooni Biotech by market cap are Warren Tea, Anjani Foods, Prudential Sugar Corporation, Kretto Syscon, Roni Households and Growington Vent.
Is Ajooni Biotech a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Ajooni Biotech's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AJOONI against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all FMCG stocks · companies starting with A · all NSE stocks · this page as text